Skip to main content
. 2018 Dec 4;33(2):160–177. doi: 10.1177/0269216318815796

Box 1.

Inclusion and exclusion criteria.

Inclusion criteria:
  • Published papers presenting empirical research on the prescribing of injectable medications ahead of need to control terminal symptoms for adults (aged 18 years and over).

  • Participants receiving care at home in the community (including nursing and residential home care settings).

  • Peer-reviewed quantitative and qualitative studies, case studies, audits, and published conference abstracts.

  • Key areas for data extraction:

    • Descriptions of current practice;

    • Patient-reported acceptance and views;

    • Family carer–reported acceptance and views;

    • Healthcare professional–reported acceptance and views;

    • Patient comfort/symptom control (reported by whom);

    • Evidence for cost-effectiveness, including impact on:

      • - Admission avoidance;

      • - Place of death;

      • - Healthcare activity;

      • - Cost of drugs.

  • Studies published up until May 2017.

  • English language full text.

Exclusion criteria:

  • Anticipatory prescribing in non-terminal care situations.

  • Prescriptions that do not include injectable medication.

  • Children (aged 17 years or under).

  • Prescribing in hospital, hospice, or prisons.

  • Papers with no new empirical data, for example, editorials, opinion papers, or narrative reviews.

  • Research examining assisted dying or euthanasia.

  • Research examining continuous sedation until death.

  • Studies concerning administration of medication via continuous subcutaneous infusion (syringe driver).

  • Grey literature.